We are live on ! Find out more
CKPT

Checkpoint Therapeutics

Delisted

CKPT was delisted on the 29th of May, 2025.

84 hedge funds and large institutions have $138M invested in Checkpoint Therapeutics in 2025 Q1 according to their latest regulatory filings, with 39 funds opening new positions, 19 increasing their positions, 15 reducing their positions, and 23 closing their positions.

New
Increased
Maintained
Reduced
Closed

288% more capital invested

Capital invested by funds: $35.5M → $138M (+$102M)

70% more first-time investments, than exits

New positions opened: 39 | Existing positions closed: 23

27% more repeat investments, than reductions

Existing positions increased: 19 | Existing positions reduced: 15

24% more funds holding

Funds holding: 6884 (+16)

18.03% more ownership

Funds ownership: 23.02%41.04% (+18%)

19% less call options, than puts

Call options by funds: $1.32M | Put options by funds: $1.62M

Holders
84
Holders Change
+16
Holders Change %
+23.53%
% of All Funds
1.13%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
% of All Funds
0.03%
New
39
Increased
19
Reduced
15
Closed
23
Calls
$1.32M
Puts
$1.62M
Net Calls
-$303K
Net Calls Change
-$254K
Name Holding Trade Value Shares
Change
Change in
Stake
HWM
26
HB Wealth Management
Georgia
$729K +$90K +27,000 +18%
SC
27
Sagefield Capital
Texas
$678K +$559K +167,800 New
KAS
28
Kestra Advisory Services
Texas
$668K -$546K -163,881 -50%
JC
29
JBF Capital
Colorado
$667K +$550K +165,000 New
State Street
30
State Street
Massachusetts
$642K +$34.3K +10,300 +7%
BMCM
31
Black Maple Capital Management
Wisconsin
$606K +$500K +150,000 New
Verition Fund Management
32
Verition Fund Management
Connecticut
$606K +$500K +150,000 New
YCM
33
Yakira Capital Management
Connecticut
$494K +$407K +122,200 New
CL
34
CSS LLC
Illinois
$458K +$378K +113,300 New
PCM
35
Prelude Capital Management
New York
$457K +$377K +113,081 New
UFM
36
Ursa Fund Management
California
$404K +$333K +100,000 New
CL
37
Choreo LLC
Illinois
$397K +$127K +38,072 +63%
Jane Street
38
Jane Street
New York
$397K +$328K +98,308 New
PCM
39
PenderFund Capital Management
British Columbia, Canada
$352K +$322K +96,600 New
Balyasny Asset Management
40
Balyasny Asset Management
Illinois
$329K +$204K +61,321 +303%
XT
41
XTX Topco
Cayman Islands
$294K +$243K +72,766 New
Two Sigma Investments
42
Two Sigma Investments
New York
$290K -$4.35K -1,305 -2%
Qube Research & Technologies (QRT)
43
Qube Research & Technologies (QRT)
United Kingdom
$288K +$89.4K +26,823 +60%
UBS Group
44
UBS Group
Switzerland
$262K -$22.8K -6,846 -10%
Envestnet Asset Management
45
Envestnet Asset Management
Illinois
$259K -$8.83K -2,650 -4%
Royal Bank of Canada
46
Royal Bank of Canada
Ontario, Canada
$243K -$99.2K -29,757 -33%
CC
47
Carlson Capital
Texas
$242K +$200K +60,000 New
PAS
48
Park Avenue Securities
New York
$242K
HHGC
49
Hunting Hill Global Capital
New York
$231K +$191K +57,200 New
PAM
50
PVG Asset Management
Colorado
$215K -$234K -70,350 -57%

CKPT Hedge Fund Activity: Q1 2025 in Review

84 of the 7,459 institutional investors tracked by Wall St. Rank reported a position in Checkpoint Therapeutics (CKPT) for Q1 2025, worth a combined $138M — up 288% from $35.5M a quarter earlier.

Buyers outnumbered sellers: 39 funds opened new CKPT positions and 23 closed out — a net gain of 16 holders — while 19 added to existing stakes and 15 trimmed.

The largest buyer was Beryl Capital Management, opening a new position worth an estimated $20.2M. The largest seller was Armistice Capital, exiting entirely with an estimated $14.3M sold.

  • 84 institutional investors held Checkpoint Therapeutics (CKPT) as of Q1 2025, up from 68 in Q4 2024.
  • Funds reported $138M of Checkpoint Therapeutics stock for Q1 2025, up 288% quarter-over-quarter.
  • 39 funds opened new Checkpoint Therapeutics positions in Q1 2025 and 23 closed out, a net change of +16 holders.
  • The largest Checkpoint Therapeutics buyer in Q1 2025 was Beryl Capital Management, an estimated $20.2M added.
  • The largest Checkpoint Therapeutics seller in Q1 2025 was Armistice Capital, an estimated $14.3M sold.

Based on aggregated 13F filings for Q1 2025.